Acurx Pharmaceuticals prices $2.5M registered direct offering of 2.46M shares at $1.015

Acurx Pharmaceuticals, Inc.

Gross proceeds ~$2.5M from 2,463,058 shares at $1.015/share in registered direct offering.
Concurrent private placement of Series E warrants to buy up to 2,463,058 shares at $0.90, exercisable for 5 years.
Net proceeds to be used for working capital and general corporate purposes; closing expected Jan 7, 2025.
Placement agent H.C. Wainwright receives 7% cash fee and warrants for 147,783 shares at $1.2688.
Affiliate investors (including CEO and Executive Chairman) purchase 167,488 shares in the offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.